Vericel Corporation (VCEL) vs Viridian Therapeutics, Inc. (VRDN)
A side-by-side comparison of Vericel Corporation and Viridian Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
VCEL
Vericel Corporation
$40.18HealthcareDelayed quote: Oct 6, 2026, 3:15 PM EDT
VRDN
Viridian Therapeutics, Inc.
$18.16HealthcareDelayed quote: Oct 6, 2026, 3:15 PM EDT
Total return — VCEL vs VRDN
growth of $100 · dividends reinvested · last 10yVCEL +1356.4% (+30.7%/yr)VRDN -83.3% (-16.4%/yr)VCEL compounded faster over this window
Log scale — wide-divergence pair
VCEL VRDN
VCEL vs VRDN: by the numbers
- •VCEL is the larger company ($2.06B vs $2.06B market cap).
- •VCEL is profitable (7.91% net margin) while VRDN runs a net loss (-544.06%).
- •VRDN grew revenue faster over the past five years (93.92% vs 15.11% CAGR).
Metrics side by side
Valuation
| Metric | VCEL | VRDN |
|---|---|---|
| P/E ratio | 85.89 | N/A |
| Forward P/E | 75.18 | N/A |
| PEG ratio | 2.18 | N/A |
| P/S ratio | 6.72 | 28.92 |
| P/B ratio | 5.56 | 3.65 |
| EV / EBITDA | 65.36 | N/A |
| FCF yield | 2.41% | N/A |
Profitability
| Metric | VCEL | VRDN |
|---|---|---|
| Gross margin | 74.56% | 99.55% |
| Operating margin | 5.95% | -512.91% |
| Net margin | 7.91% | -544.06% |
| ROE | 6.55% | -58.45% |
| ROIC | 3.79% | -39.18% |
Growth (annualized)
| Metric | VCEL | VRDN |
|---|---|---|
| Revenue CAGR (5Y) | 15.11% | 93.92% |
| EPS CAGR (5Y) | 39.14% | N/A |
| FCF CAGR (5Y) | 14.83% | N/A |
| Total return CAGR (5Y) | -4.18% | 1.64% |
Frequently asked
- Which has grown faster, VCEL or VRDN?
- Over the past five years, VRDN grew revenue faster — VCEL at a 15.11% CAGR versus VRDN at 93.92%.
- Is VCEL or VRDN more profitable?
- VCEL runs the higher net margin — VCEL at 7.91% versus VRDN at -544.06%.
- How have VCEL and VRDN total returns compared?
- Over the past 10 years, VCEL delivered 30.18% and VRDN delivered -16.41% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Vericel P/E ratioVericel ROEViridian Therapeutics ROEVericel operating marginViridian Therapeutics operating marginVericel revenue growthViridian Therapeutics revenue growthVericel free cash flowViridian Therapeutics free cash flow
Vericel & Viridian Therapeutics appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.